Kennedy Capital Management’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Kennedy Capital Management's SION Position: Q3 2026 in Review
Kennedy Capital Management sold out of Sionna Therapeutics (SION) in Q3 2026, closing a stake of 12,621 shares — an estimated $555K sold.
Kennedy Capital Management first reported a position in SION in Q4 2025 and held it in 3 quarters. The position peaked at $555K in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Kennedy Capital Management reported no remaining Sionna Therapeutics position as of Q3 2026 after selling out during the quarter.
- Kennedy Capital Management sold 12,621 Sionna Therapeutics shares in Q3 2026, an estimated $555K.
- Kennedy Capital Management first reported a position in Sionna Therapeutics in Q4 2025 and held it in 3 quarters.
- Kennedy Capital Management's Sionna Therapeutics position peaked at $555K in Q2 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.